💊 Medicine AT August 25, 2026

Depakine Chronosphere 250 mg Retardgranulat in Beuteln 250 mg (Retardgranulat)

📷 Wikipedia: Valproate · Source

ATC: N03AG01
Reason: Verzögerung bei der Herstellung
Marketing authorisation holder: Sanofi-Aventis GmbH, Turm A, 29. OG, Wienerbergstraße 11, 1100 Wien, Österreich
Affected packs: 30 Stück Schachtel, Beutel [eingeschränkt verfügbar, since 2026-09-29, resupply 2027-01-18]

⚠️

Shortage ongoing

NATRIUM VALPROAT is currently in short supply in AT.

📈 Timeline

2 days active so far

September 29, 2026 September 30, 2026

A plain-language summary will appear here shortly. Read the official notice below.

🔬 Medical / technical details (for professionals)

Active substance(s)

NATRIUM VALPROAT VALPROINSÄURE

Agency-published detail

🚫 Parallel export ban active · ATC: N03AG01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Sanofi-Aventis GmbH, Turm A, 29. OG, Wienerbergstraße 11, 1100 Wien, Österreich · Affected packs: 30 Stück Schachtel, Beutel [eingeschränkt verfügbar, since 2026-09-29, resupply 2027-01-18]

First published

August 25, 2026

Last refreshed by us

1 day ago

Severity (as classified)

Medium

Official source

https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

🔔 Stay informed

Get an email if there's an update.

Free · One click to unsubscribe

📤 Tell someone

🦋 Bluesky 𝕏 🐘 💬 WhatsApp ✈️ Telegram ✉️ Email

📋 Quick facts

Status

Shortage ongoing

Affects

First detected by us

September 29, 2026

Agency-reported start

August 25, 2026

Days active

Related alerts

Low AT resolved 4 months ago

Convulex 50 mg/ml - Sirup für Kinder (Sirup)

Convulex 50 mg/ml syrup for children is being recalled. Return any affected packs to the pharmacy. For recall details, see the official notice at the provided link.

Medium AT resolved 6 months ago

Depakine Chronosphere 500 mg Retardgranulat in Beuteln 500 mg (Retardgranulat)

Parallel export of Depakine Chronosphere 500 mg Retardgranulat in sachets is banned due to limited production capacity.

High AT resolved 6 months ago

Depakine Chronosphere 50 mg Retardgranulat in Beuteln 50 mg (Retardgranulat)

Parallel export ban in effect for Depakine Chronosphere 50 mg Retardgranulat in sachets. Supply is limited due to manufacturing capacity shortages. Affected packs: boxes of 30 sachets, available in li...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?

Depakine Chronosphere 250 mg Retardgranulat in Beuteln 250 mg (Retardgranulat). 🚫 Parallel export ban active · ATC: N03AG01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Sanofi-Aventis GmbH, Turm A, 29. OG, Wienerbergstraße 11, 1100 Wien, Österreich · Affected packs: 30 Stück Schachtel, Beutel [eingeschränkt verfügbar, since 20...

▸ When was this alert issued?

This alert was issued on August 25, 2026 by BASG (Austria).

▸ Which countries are affected?

The alert applies to Austria.

▸ How serious is this alert?

Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.

▸ What should I do?

If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.

▸ Where can I find the official notice?

The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.